Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in Schizophrenia
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
we aim to examine whether a representative atypical antipsychotic, quetiapine, has different
effects from conventional antipsychotics on the magnetic resonance spectroscopy (MRS) markers
in schizophrenia patients.